BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34189277)

  • 21. Wild-type and mutant (G2019S) leucine-rich repeat kinase 2 (LRRK2) associate with subunits of the translocase of outer mitochondrial membrane (TOM) complex.
    Neethling A; Engelbrecht L; Loos B; Kinnear C; Theart R; Abrahams S; Niesler T; Mellick GD; Williams M; Bardien S
    Exp Cell Res; 2019 Feb; 375(2):72-79. PubMed ID: 30597143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological manipulations of autophagy modulate paraquat-induced cytotoxicity in PC12 cells.
    Zhou Q; Zhang H; Wu Q; Shi J; Zhou S
    Int J Biochem Mol Biol; 2017; 8(2):13-22. PubMed ID: 28695042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.
    Podlesniy P; Vilas D; Taylor P; Shaw LM; Tolosa E; Trullas R
    Neurobiol Dis; 2016 Oct; 94():10-7. PubMed ID: 27260835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells: Role for PI3K/Akt/Nrf2 pathway.
    de Oliveira MR; Ferreira GC; Schuck PF
    Toxicol In Vitro; 2016 Apr; 32():41-54. PubMed ID: 26686574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
    Milanese C; Tapias V; Gabriels S; Cerri S; Levandis G; Blandini F; Tresini M; Shiva S; Greenamyre JT; Gladwin MT; Mastroberardino PG
    Antioxid Redox Signal; 2018 Jan; 28(1):44-61. PubMed ID: 28816057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
    Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
    Elife; 2020 Feb; 9():. PubMed ID: 32057291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
    Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA
    Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models.
    Chittoor-Vinod VG; Villalobos-Cantor S; Roshak H; Shea K; Abalde-Atristain L; Martin I
    J Neurosci; 2020 Aug; 40(32):6234-6249. PubMed ID: 32605938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson's Disease Associated α-Synuclein Levels.
    Huang CY; Sivalingam K; Shibu MA; Liao PH; Ho TJ; Kuo WW; Chen RJ; Day CH; Viswanadha VP; Ju DT
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?
    Loeffler DA; Aasly JO; LeWitt PA; Coffey MP
    J Parkinsons Dis; 2019; 9(3):467-488. PubMed ID: 31322581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The
    Ming F; Tan J; Qin L; Zhang H; Tang J; Tan X; Wang C
    Biomed Res Int; 2020; 2020():4658109. PubMed ID: 33029508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy.
    Jaroonwitchawan T; Chaicharoenaudomrung N; Namkaew J; Noisa P
    Neurosci Lett; 2017 Jan; 636():40-47. PubMed ID: 27793699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson's disease.
    Harish G; Venkateshappa C; Mythri RB; Dubey SK; Mishra K; Singh N; Vali S; Bharath MM
    Bioorg Med Chem; 2010 Apr; 18(7):2631-8. PubMed ID: 20227282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects.
    Deus CM; Pereira SP; Cunha-Oliveira T; Pereira FB; Raimundo N; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165615. PubMed ID: 31759069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.
    Mancini A; Mazzocchetti P; Sciaccaluga M; Megaro A; Bellingacci L; Beccano-Kelly DA; Di Filippo M; Tozzi A; Calabresi P
    Front Cell Neurosci; 2020; 14():158. PubMed ID: 32848606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.